203 related articles for article (PubMed ID: 8338890)
1. [The complement system].
Taran LD
Biokhimiia; 1993 May; 58(5):780-7. PubMed ID: 8338890
[TBL] [Abstract][Full Text] [Related]
2. Human peritoneal macrophages. Production in vitro of the active terminal complement components C5 to C9 and a functional alternative pathway of complement. Brief report.
Hetland G; Bungum L
APMIS; 1988 Jan; 96(1):89-92. PubMed ID: 3345254
[TBL] [Abstract][Full Text] [Related]
3. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
Hänsch GM; Hammer CH; Mayer MM; Shin ML
J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
[TBL] [Abstract][Full Text] [Related]
4. Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps.
Ollert MW; Kadlec JV; David K; Petrella EC; Bredehorst R; Vogel CW
J Immunol; 1994 Sep; 153(5):2213-21. PubMed ID: 8051421
[TBL] [Abstract][Full Text] [Related]
5. Terminal complement components play a role in the expression of C5a.
Gresham HD; Renfer L; Hammer CH; Frank MM
J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
[TBL] [Abstract][Full Text] [Related]
6. Freeze-thaw activation of the complement attack phase: I. Separation of two steps in the formation of the active C--56 complex.
Dessauer A; Rother U; Rother K
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():75-81. PubMed ID: 6587745
[TBL] [Abstract][Full Text] [Related]
7. The human alternative complement pathway: biology and immunopathology of activation and regulation.
Kazatchkine MD; Nydegger UE
Prog Allergy; 1982; 30():193-234. PubMed ID: 7041132
[No Abstract] [Full Text] [Related]
8. The attack phase of human complement: differentiation between membrane binding and complex formation by the detection of neoantigen expression in situ. A morphometric immunoferritin study.
Balkarowa-Ständer J; Rother U; Rauterberg EW
J Immunol; 1981 Sep; 127(3):1089-93. PubMed ID: 7264298
[TBL] [Abstract][Full Text] [Related]
9. Expression of terminal complement components by human keratinocytes.
Timár KK; Dallos A; Kiss M; Husz S; Bos JD; Asghar SS
Mol Immunol; 2007 Apr; 44(10):2578-86. PubMed ID: 17267037
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
Ollert MW; Kadlec JV; Petrella EC; Bredehorst R; Vogel CW
Cancer Res; 1993 Feb; 53(3):592-9. PubMed ID: 8425193
[TBL] [Abstract][Full Text] [Related]
11. Relationships among the complement, kinin, coagulation and fibrinolytic systems in the inflammatory reaction.
Sundsmo JS; Fair DS
Clin Physiol Biochem; 1983; 1(2-5):225-84. PubMed ID: 6241121
[No Abstract] [Full Text] [Related]
12. Synergistic inhibition of human cell-mediated cytotoxicity by complement component antisera indicates that target cell lysis may result from an enzymatic cascade involving granzymes and perforin.
Brahmi Z; Csipo I; Bochan MR; Su B; Montel AH; Morse PA
Nat Immun; 1995 Sep; 14(5-6):271-85. PubMed ID: 8933821
[TBL] [Abstract][Full Text] [Related]
13. Structural biology of the membrane attack complex.
Sonnen AF; Henneke P
Subcell Biochem; 2014; 80():83-116. PubMed ID: 24798009
[TBL] [Abstract][Full Text] [Related]
14. Conformationally altered hyaluronan restricts complement classical pathway activation by binding to C1q, C1r, C1s, C2, C5 and C9, and suppresses WOX1 expression in prostate DU145 cells.
Hong Q; Kuo E; Schultz L; Boackle RJ; Chang NS
Int J Mol Med; 2007 Jan; 19(1):173-9. PubMed ID: 17143562
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic action and other metabolic consequences of terminal complement proteins.
Shin ML; Carney DF
Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
[No Abstract] [Full Text] [Related]
16. [The complement system--structure, activation, regulation and function].
Bjørge L
Tidsskr Nor Laegeforen; 1999 Jan; 119(2):226-33. PubMed ID: 10081355
[TBL] [Abstract][Full Text] [Related]
17. Complement: function and clinical relevance.
Williams LW; Burks AW; Steele RW
Ann Allergy; 1988 Apr; 60(4):293-300. PubMed ID: 3282455
[TBL] [Abstract][Full Text] [Related]
18. Regulation of complement activation at the C3-level by serum resistant leptospires.
Meri T; Murgia R; Stefanel P; Meri S; Cinco M
Microb Pathog; 2005 Oct; 39(4):139-47. PubMed ID: 16169184
[TBL] [Abstract][Full Text] [Related]
19. Human polymorphonuclear leukocytes store large amounts of terminal complement components C7 and C6, which may be released on stimulation.
Høgåsen AK; Würzner R; Abrahamsen TG; Dierich MP
J Immunol; 1995 May; 154(9):4734-40. PubMed ID: 7722325
[TBL] [Abstract][Full Text] [Related]
20. Genetics of the complement system.
Crawford K; Alper CA
Rev Immunogenet; 2000; 2(3):323-38. PubMed ID: 11256743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
